
SVG

FasterCures
Featured
Report
Scaling and Sustaining Better Health Outcomes Through Prevention
Preventable illnesses remain a leading cause of death worldwide. Non-communicable diseases such as cardiovascular disease...
Read
Report
Featured
Report
Scaling and Sustaining Better Health Outcomes Through Prevention
Preventable illnesses remain a leading cause of death worldwide. Non-communicable diseases such as cardiovascular disease...
Read
Report
FasterCures is working to build a system that is effective, efficient, and driven by a clear vision: patient needs above all else. We believe that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them.
SVG

FasterCures
Practice Areas
Today's biomedical research system is often siloed, bureaucratic, and too slow to meet the needs of patients across the globe. We accelerate biomedical science and innovation to remove unnecessary barriers so that lifesaving and life-enhancing treatments can reach those who need them as rapidly and as safely as possible.
Accelerating Innovation
Removing barriers to innovations that hold great promise for patients, and facilitating dialogue on the path forward for new technologies.
Advancing Health Around the World
Promoting investments and policies to build early warning systems as a core component of surveillance strategies to identify threats of the pandemic potential.
Engaging Patients in Research and Health
Strengthening the ability of patient foundations, non-profit organizations, and patients to engage with the R&D process from beginning to end in full partnership.
Improving the R&D Environment
Preserving the lessons learned from COVID-19, ensuring the engagement of diverse communities in research, and supporting efforts to speed clinical trials and build inclusive research infrastructure.
FasterCures
Most Recent Content
Prescription Drug User Fee Act VIII (PDUFA)
FasterCures at the Milken Institute is honored to provide our response to the Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments [FDA–2025–N–0816]. As a nonprofit, nonpartisan think tank, the Milken...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Ensuring Lawful Regulation and Unleashing Innovation To Make America Healthy Again
The FasterCures team at the Milken Institute is honored to provide its expert response to the Request for Information regarding Ensuring Lawful Regulation and Unleashing Innovation to Make America Healthy Again, as part of the President’s...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Medicare Drug Price Negotiation Program Draft Guidance
The FasterCures team at the Milken Institute is honored to provide its expert response to the Request for Comments on the Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191–1198 of the Social Security...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice [Docket No. FDA-2024-D...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle
The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle [Docket No. FDA-2015-D-1580].Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
Dr. Richard Pazdur Director Oncology Center of Excellence US Food and Drug Administration Beltsville, MD 20705 Dr. Michelle Tarver Acting Director Center for Devices and Radiological Health US Food and Drug Administration Silver Spring, MD...Read LetterComment Letter: Action Plans to Improve Diversity in Clinical Studies
ImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees
The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees; Public Meeting; Request for Comments...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Request for Information on Next-Generation Cures Bill
The Honorable Diana DeGette US House of Representatives Washington, DC 20515 The Honorable Larry Bucshon, MD US House of Representatives Washington, DC 20515 Re: Request for Information on Next-Generation Cures Bill Dear Representatives...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Medicare Drug Price Negotiation Program
The FasterCures team at the Milken Institute is honored to provide its expert response to the Request for Comments on the Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191–1198 of the Social Security...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Get the latest from FasterCures
Subscribe to the FasterCures newsletter for updates on our latest publications, programmatic initiatives, and policy news, as well as periodic announcements of events.

FasterCures
Our Team
Image

Ayodola Anise
Senior Director, Operations, Milken Institute Health
Image

June Cha, PhD
Policy Director, FasterCures, Milken Institute Health
Image

Sung Hee Choe
Managing Director, FasterCures, Milken Institute Health
Image

Erin Cieslewski
Associate, FasterCures
Image

Hadly Clark
Director, FasterCures, Milken Institute Health
Image

Brenda Huneycutt
Senior Director, International, Milken Institute Health
Image

Esther Krofah
Executive Vice President, Milken Institute Health
Image

Lisa Lewis
Director, FasterCures, Milken Institute Health
Image

Sruthi Meka
Senior Associate, FasterCures
Image

Raymond Puerini
Director, FasterCures, Milken Institute Health
Image

Kristin Schneeman
Senior Director, FasterCures, Milken Institute Health
Image

Erika Stratmann
Director, Communications, Milken Institute Health
Image

Aidan Suski
Associate, FasterCures
Image

Aneri Suthar
Senior Associate, FasterCures, Milken Institute Health
Image

Ainslie Tisdale
Associate Director, FasterCures, Milken Institute Health
Image

Amanda Wagner Gee
Associate Director, FasterCures, Milken Institute Health
Image

Mark Williams
Associate Director, FasterCures, Milken Institute Health
FasterCures
Leaders
FasterCures Advisory Board
The FasterCures Advisory Board includes policy experts, public health advocates, and leaders in biomedical innovation. Together with the FasterCures staff, they identify areas of opportunity across the healthcare and biomedical research...
Learn moreFasterCures Business Council
The FasterCures Business Council brings together leaders committed to FasterCures’ mission to speed treatments and cures. Given the leadership and expertise that they have demonstrated across the health landscape, members have the...
Learn moreChangemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem? That is a question that will be tested by the members of our new advisory group, which brings together the chief executives of 22 leading nonprofit, patient...
Learn more